{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:20:34Z","timestamp":1791066034301,"version":"4.1.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,8,1]]},"abstract":"<jats:title>abstract<\/jats:title>\n               <jats:p>Although human immunodeficiency virus (HIV) disease is increasing rapidly among women, no prior studies have investigated gender-based therapeutic strategies for the treatment of acquired immunodeficiency syndrome (AIDS) and its complications in this population. Markedly decreased serum androgen levels have been demonstrated in women with AIDS and may be a contributing factor to the wasting syndrome in this population. To assess the effects of androgen replacement therapy in women with AIDS wasting, we conducted a randomized, placebo-controlled, pilot study of transdermal testosterone administration. The primary aim of the study was to determine efficacy in terms of the change in serum testosterone levels, safety parameters and tolerability. A secondary aim of the study was to investigate testosterone effects on weight, body composition, quality of life, and functional indexes.<\/jats:p>\n               <jats:p>Fifty-three ambulatory women with the AIDS wasting syndrome defined as weight less than 90% of ideal body weight or weight loss of more than 10% of the preillness maximum, free of new opportunistic infection within 6 weeks of study initiation, and with screening serum levels of free testosterone less than the mean of the normal reference range (&amp;lt;3 pg\/mL) were enrolled in the study. Subjects were age 37 \u00b1 1 yr old (mean \u00b1 sem), weighed 92 \u00b1 2% of ideal body weight, and had lost 17 \u00b1 1% of their maximum weight. CD4 count was 324 \u00b1 36 cells\/mm3, and viral burden was 102,382 \u00b1 28,580 copies.<\/jats:p>\n               <jats:p>Subjects were randomized into three treatment groups, in which two placebo patches (PP), one active\/one placebo patch (AP group), or two active patches (AA group) were applied twice weekly to the abdomen for 12 weeks. The expected nominal delivery rates of testosterone were 150 and 300 \u03bcg\/day, respectively, for the AP and AA groups. Forty-five subjects completed the study (PP group, n = 13; AP group, n = 14; AA group, n = 18). Two additional subjects from the PP group and two from the AP group were included in the intent to treat analysis. Serum free testosterone levels increased significantly from 1.2 \u00b1 0.2 to 5.9 \u00b1 0.8 pg\/mL (AP) and from 1.9 \u00b1 0.4 to 12.4 \u00b1 1.6 pg\/mL (AA) in response to testosterone administration (P &amp;lt; 0.0001 for comparison of AA vs. PP and AP vs. PP; normal range, 1.3\u20136.8 pg\/mL). Testosterone administration was generally well tolerated locally and systemically, with no adverse trends in hirsutism scores, lipid profiles, or liver function tests.<\/jats:p>\n               <jats:p>Weight increased significantly in the AP group (1.9 \u00b1 0.7 kg) vs. the PP group (0.6 \u00b1 0.8 kg; P = 0.043), but did not increase significantly in the AA group (0.9 \u00b1 0.4 kg; P = 0.263 vs. PP, by mixed effects model assessing the interaction of time and treatment on all available data, one-tailed test). Improved social functioning (P = 0.024, by one-tailed test) and a trend toward improved pain score (P = 0.059) were observed in the AP vs. the PP-treated patients (RAND 36-Item Health Survey questionnaire). Five of six previously amenorrheic patients in the AP group had spontaneous resumption of menses compared to only one of four amenorrheic patients in the AA group (P = 0.045 for comparison of actual number of periods during the study).<\/jats:p>\n               <jats:p>This study is the first investigation of testosterone administration in women with AIDS wasting. We demonstrate a novel method to augment testosterone levels in such patients that is safe and well tolerated during short term administration. At the lower of the two doses administered in this study, testosterone therapy was associated with positive trends in weight gain and quality of life. Higher, more supraphysiological, dosing was not associated with positive trends in weight or overall well-being. These data suggest that testosterone administration may improve the status of women with AIDS wasting. Further studies are needed to assess the effects of testosterone on weight in HIV-infected women and to define the optimal therapeutic window for testosterone administration in this population.<\/jats:p>","DOI":"10.1210\/jcem.83.8.5051","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:03:29Z","timestamp":1389200609000},"page":"2717-2725","source":"Crossref","is-referenced-by-count":6,"title":["Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study1"],"prefix":"10.1210","volume":"83","author":[{"given":"Karen","family":"Miller","sequence":"first","affiliation":[{"name":"Neuroendocrine (S.G., K.M. C.C., C.A.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Corcoran","sequence":"additional","affiliation":[{"name":"Neuroendocrine (S.G., K.M. C.C., C.A.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Neuroendocrine (S.G., K.M. C.C., C.A.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Caramelli","sequence":"additional","affiliation":[{"name":"TheraTech, Inc. (C.D., K.C., N.M.), Salt Lake City, Utah 84108"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Anderson","sequence":"additional","affiliation":[{"name":"the General Clinical Research Center (E.A., D.S.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cotton","sequence":"additional","affiliation":[{"name":"Infectious Disease (N.B., D.C.) Departments, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesli","family":"Basgoz","sequence":"additional","affiliation":[{"name":"Infectious Disease (N.B., D.C.) Departments, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hirschhorn","sequence":"additional","affiliation":[{"name":"Dimock Community Health Center (L.H.), Boston, Massachusetts 02119"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tuomala","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Brigham and Women\u2019s Hospital (R.T.), Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schoenfeld","sequence":"additional","affiliation":[{"name":"the General Clinical Research Center (E.A., D.S.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Daugherty","sequence":"additional","affiliation":[{"name":"TheraTech, Inc. (C.D., K.C., N.M.), Salt Lake City, Utah 84108"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Mazer","sequence":"additional","affiliation":[{"name":"TheraTech, Inc. (C.D., K.C., N.M.), Salt Lake City, Utah 84108"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grinspoon","sequence":"additional","affiliation":[{"name":"Neuroendocrine (S.G., K.M. C.C., C.A.), Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613474085500_R1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/ajcn\/42.6.1255","article-title":"Body composition studies in patients with the acquired immunodeficiency syndrome.","volume":"42","author":"Kotler","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"2020071613474085500_R2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcn\/50.3.444","article-title":"Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS.","volume":"50","author":"Kotler","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"2020071613474085500_R3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jama.1997.03550110049035","article-title":"AIDS in women in the United States.","volume":"278","author":"Wortley","year":"1997","journal-title":"JAMA"},{"key":"2020071613474085500_R4","first-page":"1332","article-title":"Body composition and endocrine function in women with AIDS wasting.","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R5","first-page":"3","article-title":"Revision of the CDC surveillance definition for acquired immunodeficiency syndrome.","volume":"36","year":"1987","journal-title":"Morbid Mortal Weekly Rep"},{"key":"2020071613474085500_R6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/51.6.1106","article-title":"Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition.","volume":"51","author":"Mazess","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"2020071613474085500_R7","first-page":"556","article-title":"Clinical assessment of body hair growth in women.","volume":"31","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R8","year":"1992"},{"key":"2020071613474085500_R9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-121-6-199409150-00002","article-title":"Megestrol acetate in patients with AIDS and cachexia.","volume":"121","author":"Oster","year":"1994","journal-title":"Ann Intern Med"},{"key":"2020071613474085500_R10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(85)90465-6","article-title":"Simple method for measurement of lower extremity muscle strength.","volume":"78","author":"Csuka","year":"1984","journal-title":"Am J Med"},{"key":"2020071613474085500_R11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0021-9681(85)90035-9","article-title":"How should we measure function in patients with chronic heart and lung disease?","volume":"38","author":"Guyatt","year":"1985","journal-title":"J Chronic Dis"},{"key":"2020071613474085500_R12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cup and go:\u201d a test of basic functional mobility for frail elderly persons.","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"2020071613474085500_R13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/oxfordjournals.aje.a114915","article-title":"A mail survey of physical activity habits as related to measured physical fitness.","volume":"127","author":"Kohl","year":"1988","journal-title":"Am J Epidemiol"},{"key":"2020071613474085500_R14","first-page":"718","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values.","volume":"327","author":"Jordan","year":"1992","journal-title":"N Engl J Med"},{"key":"2020071613474085500_R15","first-page":"165","article-title":"Update: trends in AIDS incidence, deaths and prevalence\u2013United States, 1996.","volume":"46","year":"1997","journal-title":"Morbid Mortal Weekly Rep"},{"key":"2020071613474085500_R16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting.","volume":"125","author":"Schambelan","year":"1996","journal-title":"Ann Intern Med"},{"key":"2020071613474085500_R17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9378(85)90001-8","article-title":"Differential symptom response to parenteral estrogen and\/or androgen administration in the surgical menopause.","volume":"151","author":"Sherwin","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613474085500_R18","first-page":"2198","article-title":"Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women\u2013a clinical research center study.","volume":"81","author":"Lovejoy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R19","first-page":"262","article-title":"Liver damage from long-term methyltestosterone.","volume":"2","author":"Westaby","year":"1977","journal-title":"Lancet"},{"key":"2020071613474085500_R20","year":"1996"},{"key":"2020071613474085500_R21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","article-title":"Adrenal and gonadal androgen secretion in normal females.","volume":"15","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"2020071613474085500_R22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jcem-28-8-1105","article-title":"Further study of the factors affecting the metabolic clearance of testosterone in man.","volume":"28","author":"Southren","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2125.1997.00644.x","article-title":"Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.","volume":"44","author":"Eagling","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"2020071613474085500_R24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-121-6-199409150-00001","article-title":"Megestrol acetate in patients with AIDS-related cachexia.","volume":"121","author":"Von Roenn","year":"1994","journal-title":"Ann Intern Med"},{"key":"2020071613474085500_R25","first-page":"225","article-title":"Lean body mass-body fat interrelationships in humans.","volume":"45","year":"1987","journal-title":"Nutr Rev"},{"key":"2020071613474085500_R26","first-page":"393","article-title":"Autoregulation of body composition during weight recovery in human: the Minnesota Experiment revisited.","volume":"20","author":"Dulloo","year":"1996","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071613474085500_R27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0031-9384(79)90045-3","article-title":"Effects of testosterone on body weight and adipose tissue: role of aromatization.","volume":"23","author":"Gray","year":"1979","journal-title":"Physiol Behav"},{"key":"2020071613474085500_R28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3181\/00379727-100-24682","article-title":"Changes in body weight of normal and castrated rats by different doses of testosterone propionate.","volume":"100","author":"Kochakian","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071613474085500_R29","first-page":"407","article-title":"Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.","volume":"82","author":"Bhasin","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R30","first-page":"3469","article-title":"Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men\u2013a clinical research center study.","volume":"81","author":"Brodsky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R31","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.","volume":"81","author":"Katznelson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R32","first-page":"1092","article-title":"Effects of testosterone supplementation in the aging male.","volume":"75","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R33","first-page":"E820","article-title":"Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis","volume":"269","author":"Urban","year":"1995","journal-title":"Am J Physiol."},{"key":"2020071613474085500_R34","first-page":"2044","article-title":"Long-term testosterone admininistration increases visceral fat in female to male transsexuals.","volume":"82","author":"Elbers","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613474085500_R35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-116-2-129","article-title":"Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study Instrument.","volume":"116","author":"Wachtel","year":"1992","journal-title":"Ann Intern Med"},{"key":"2020071613474085500_R36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00435968","article-title":"Health-related quality of life of HIV-infected women: evidence for the reliability, validity, and responsiveness of the Medical Outcomes Study Short-Form 20. Qual.","volume":"5","author":"Smith","year":"1996","journal-title":"Life Res"},{"key":"2020071613474085500_R37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.185.4155.949","article-title":"Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset.","volume":"185","author":"Frisch","year":"1974","journal-title":"Science"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/8\/2717\/10401179\/jcem2717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/8\/2717\/10401179\/jcem2717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:39:54Z","timestamp":1594946394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/83\/8\/2717\/2660479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8,1]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1998,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.83.8.5051","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8,1]]}}}